Xuanzhu Biopharmaceutical Co., Ltd. (stock code: 02575) published its Monthly Return for Equity Issuer for the period ended 31 January 2026. According to the report, the total issued share capital remains at 517,947,790 shares, divided into 160,701,996 H shares (listed on the Stock Exchange of Hong Kong) and 357,245,794 unlisted shares. The H shares have a par value of RMB 1 each, with a confirmed public float requirement of 24.96%.

No movement in equity or treasury shares is reported for the month. The Monthly Return indicates that there were no repurchases, redemptions, or other changes in the Company’s share capital structure within this period.